Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Investigation

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI39843PMID 20093777PMCID PMC2810080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial

  2009cited by this paper
• Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy

  2009cited by this paper
• Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae

  2009cited by this paper
• Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

  2009influential reference
• Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin.

  2009cited by this paper
• Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis.

  2009cited by this paper
• Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia.

  2009cited by this paper
• Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

  2009cited by this paper
• Prior statin use is associated with improved outcomes in community-acquired pneumonia.

  2008cited by this paper
• MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

  2008cited by this paper
• Calcium efflux is essential for bacterial survival in the eukaryotic host

  2008influential reference
• Pneumolysin: a double-edged sword during the host-pathogen interaction.

  2008cited by this paper
• The MACPF/CDC family of pore-forming toxins

  2008cited by this paper
• Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.

  2008cited by this paper
• Statins and the vascular endothelial inflammatory response.

  2007cited by this paper
• Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions

  2007cited by this paper
• Statins and sepsis: multiple modifications at multiple levels.

  2007cited by this paper
• Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor.

  2007cited by this paper
• Cytokines and plasma factors in sickle cell disease

  2007cited by this paper
• Simvastatin suppresses experimental aortic aneurysm expansion.

  2006cited by this paper
• Potential therapeutic role for statins in respiratory disease

  2006cited by this paper
• Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology

  2006cited by this paper
• Pneumonia: the forgotten killer of children.

  2006cited by this paper
• Erratum: β-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae (Infection and Immunity (2005) 73, 12 (7827-7835))

  2006cited by this paper
• Acridine Orange/Ethidium Bromide (AO/EB) Staining to Detect Apoptosis.

  2006cited by this paper
• β-Arrestin 1 Participates in Platelet-Activating Factor Receptor-Mediated Endocytosis of Streptococcus pneumoniae

  2006cited by this paper
• β-Arrestin 1 Participates in Platelet-Activating Factor Receptor-Mediated Endocytosis of Streptococcus pneumoniae

  2005cited by this paper
• Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury.

  2005cited by this paper
• Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

  2004cited by this paper
• Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin.

  2004influential reference
• HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis

  2004cited by this paper
• Microarray Analysis of Pneumococcal Gene Expression during Invasive Disease

  2004cited by this paper
• Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis

  2004cited by this paper
• Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice.

  2004cited by this paper
• The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.

  2003cited by this paper
• Transgenic sickle mice have vascular inflammation.

  2003cited by this paper
• HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

  2003cited by this paper
• Endothelium-dependent effects of statins.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• ERRATA

  2001cited by this paper
• The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

  2000cited by this paper
• Investigation

  2000cited by this paper
• Pneumolysin, a Protein Toxin of Streptococcus pneumoniae, Induces Nitric Oxide Production from Macrophages

  1999cited by this paper
• Infections and immunizations of children with sickle cell disease.

  1999cited by this paper
• Infections and immunizations of children with sickle cell disease.

  1999cited by this paper
• Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.

  1997cited by this paper
• The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System

  1997cited by this paper
• The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

  1996cited by this paper
• Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor

  1995cited by this paper
• The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity

  1989cited by this paper
• Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

  1986cited by this paper
• Nasopharyngeal carriage of pneumococci in children with sickle cell disease

  1980cited by this paper
• A study of the genetic material determining an enzyme in Pneumococcus.

  1960influential reference
• A study of the genetic material determining an enzyme activity in Pneumococcus

  1960cited by this paper

• Biofilm formation during pneumococcal carriage imprints naturally acquired humoral immunity

  2025cites this paper
• Host-inspired anti-virulence strategies against membrane-targeting bacterial toxins: modification and mimicry.

  2025cites this paper
• Impact of Long-Term Statin Therapy on Incidence and Severity of Community-Acquired Pneumonia: A Real-World Data Analysis

  2025cites this paper
• Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins

  2024cites this paper
• The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy

  2023cites this paper
• Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association

  2023cites this paper
• Drug Repurposing: Insights into Current Advances and Future Applications.

  2023cites this paper
• Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review

  2023cites this paper
• Story of Pore-Forming Proteins from Deadly Disease-Causing Agents to Modern Applications with Evolutionary Significance

  2023cites this paper
• Determinants of urinary tract infection in hospitalized patients with acute ischemic stroke

  2023cites this paper
• The Yin and Yang of Pneumolysin During Pneumococcal Infection

  2022cites this paper
• Simvastatin attenuates inflammatory process on LPS-induced acute lung injury in mice.

  2022cites this paper
• Matcha Green Tea Exhibits Bactericidal Activity against Streptococcus pneumoniae and Inhibits Functional Pneumolysin

  2021cites this paper
• Streptococcus pneumoniae and Its Virulence Factors H2O2 and Pneumolysin Are Potent Mediators of the Acute Chest Syndrome in Sickle Cell Disease

  2021cites this paper
• Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19

  2021cites this paper
• Predicting interfacial hot-spot residues that stabilize protein-protein interfaces in oligomeric membrane-toxin pores through hydrogen bonds and salt bridges

  2020cites this paper
• Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds against Escherichia coli

  2020cites this paper
• Pneumolysin: Pathogenesis and Therapeutic Target

  2020cites this paper
• Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance

  2020cites this paper
• Challenges and Opportunities in Repurposing of Drugs: Mini Review

  2020cites this paper
• Convergence of Inflammatory Pathways in Allergic Asthma and Sickle Cell Disease

  2020cites this paper
• Hypoxia‐inducible factor and bacterial infections in chronic obstructive pulmonary disease

  2020cites this paper
• Pleiotropic effects of statins via interaction with the lipid bilayer: A combined approach.

  2020cites this paper
• Allergic inflammation alters the lung microbiome and hinders synergistic co-infection with H1N1 influenza virus and Streptococcus pneumoniae in C57BL/6 mice

  2019cites this paper
• Allergic inflammation hinders synergistic viral-bacterial co-infection in C57BL/6 mice

  2019cites this paper
• Cardiovascular complications following pneumonia: focus on pneumococcus and heart failure

  2019cites this paper
• An In silico Algorithm for Identifying Amino Acids that Stabilize Oligomeric Membrane-Toxin Pores through Electrostatic Interactions

  2019cites this paper
• Mevastatin promotes healing by targeting Caveolin-1 to restore EGFR signaling.

  2019cites this paper
• Are the Statins promising antifungal agents against invasive candidiasis?

  2019cites this paper
• Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice

  2018cites this paper
• Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking

  2018cites this paper
• Statins: a viable candidate for host-directed therapy against infectious diseases

  2018cites this paper
• Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.

  2018cites this paper
• Anti-Candida albicans Activity of Thiazolylhydrazone Derivatives in Invertebrate and Murine Models

  2018cites this paper
• Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice

  2018cites this paper
• Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection

  2018cites this paper
• Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice

  2018cites this paper
• Prise en charge des infections à Streptococcus pneumoniae : ce qui a changé en 15 ans

  2017cites this paper
• Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa

  2017cites this paper
• Pneumolysin as a potential therapeutic target in severe pneumococcal disease.

  2017cites this paper
• Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.

  2017cites this paper
• Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds

  2017cites this paper
• Farnesyltransferase inhibitor FTI‐277 inhibits PD‐L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation

  2017cites this paper
• Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin

  2017cites this paper
• Bacteria and endothelial cells: a toxic relationship.

  2017cites this paper
• Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

  2017cites this paper
• Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

  2017cites this paper
• Simvastatin reduces vaso‐occlusive pain in sickle cell anaemia: a pilot efficacy trial

  2017cites this paper
• in the lung streptococcal M1 protein-induced neutrophil infiltration Simvastatin regulates CXC chemokine formation in

  2016cites this paper
• Is There Potential for Repurposing Statins as Novel Antimicrobials?

  2016cites this paper
• Heme changes HIF-α, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies.

  2016cites this paper
• Proposed Title : Statins as next generation antimicrobials : Is there potential for repurposing ? 1 Short Title : Statins inhibit bacterial growth and virulence

  2016cites this paper
• The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia

  2016cites this paper
• Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis

  2016cites this paper
• Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia

  2016cites this paper
• Pneumolysin Mediates Platelet Activation In Vitro

  2016cites this paper
• University of Birmingham Pneumolysin Mediates Platelet Activation In Vitro

  2016cites this paper
• Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach.

  2016cites this paper
• Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.

  2016cites this paper
• Statin-conferred enhanced cellular resistance against bacterial pore-forming toxins in airway epithelial cells.

  2015cites this paper
• A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus

  2015cites this paper
• Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice

  2015cites this paper
• Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

  2015cites this paper
• Increased statin prescribing does not lower pneumonia risk.

  2015cites this paper
• Self-controlled designs to control confounding

  2015cites this paper
• How we prevent and manage infection in sickle cell disease

  2015cites this paper
• The effects of statin therapy on pneumonia outcomes

  2015cites this paper
• Pneumococcal Invasion: Development of Bacteremia and Meningitis

  2015cites this paper
• Mechanisms of Predisposition to Pneumonia

  2015cites this paper
• The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance.

  2015cites this paper
• Cardiotoxicity during invasive pneumococcal disease.

  2015cites this paper
• Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus

  2015cites this paper
• Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies.

  2015cites this paper
• Perfluorocarbon emulsion therapy attenuates pneumococcal infection in sickle cell mice.

  2015cites this paper
• Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking

  2015cites this paper
• Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity

  2014cites this paper
• Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.

  2014cites this paper
• Early goal directed therapy for adult meningitis in Malawi

  2014cites this paper
• NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis.

  2014cites this paper
• Fulminant pneumococcal infection

  2014cites this paper
• Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients

  2014cites this paper
• Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

  2014cites this paper
• Streptococcus pneumoniae Translocates into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function

  2014cites this paper
• Capacity To Induce T Cell Immunity B Cell Activation, Resulting in a Reduced Specifically Interferes with CD40-Dependent Inhibition of Protein Geranylgeranylation

  2014cites this paper
• Inflammatory mediators of endothelial injury in sickle cell disease.

  2014cites this paper
• Are statins beneficial for viral pneumonia?

  2013cites this paper
• Statins Decrease Lung Inflammation in Mice by Upregulating Tetraspanin CD9 in Macrophages

  2013cites this paper
• Treating influenza with statins and other immunomodulatory agents.

  2013cites this paper
• Potential role for statins in sickle cell disease

  2013cites this paper
• Effect of pravastatin and fosinopril on recurrent urinary tract infections.

  2013cites this paper
• Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape

  2013cites this paper
• Mechanistic links between acute respiratory tract infections and acute coronary syndromes.

  2013cites this paper
• The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

  2013cites this paper
• Pneumococcal Meningitis Pathogenesis and Pathophysiology of

  2013cites this paper
• Identifying functional single nucleotide polymorphisms in two candidate genes (PROC and PCSK9) in sepsis

  2013cites this paper
• Current concepts in host–microbe interaction leading to pneumococcal pneumonia

  2013cites this paper
• Anti-Inflammatory Effects of Statins in Sickle Cell Disease

  2013cites this paper
• Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia

  2012cites this paper
• Simvastatin Protects Against T Cell Immune Dysfunction in Abdominal Sepsis

  2012cites this paper
• The platelet activating factor receptor: a new anti-infective target in respiratory disease?

  2012cites this paper